From the 1Massachusetts General Hospital, Boston, Massachusetts; 2Boehringer Ingelheim GmbH, Ingelheim, Germany; 3PRC Health Services Research and Management Consulting, Washington, DC; 4RTI Health Solutions, Research Triangle Park, North Carolina; and 5RTI Health Solutions, Waltham, Massachusetts.
See related editorial on page 968.
Dr. Segreti is currently affiliated with ASG, Inc., Cary, North Carolina.
Funded by Boehringer Ingelheim International GmbH.
The authors thank TNS Healthcare Inc., especially Kerri Lehrhaupt, for data collection; Lee Bennett From RTI Health Solutions for performing the statistical analysis; and Dr. Ray Rosen of New England Research Institutes for providing expert clinical advice.
Corresponding author: Dr. Jan L. Shifren, Vincent OB/GYN Service, Massachusetts General Hospital, 55 Fruit Street, Yawkey 10-A, Boston, MA 02114; e-mail: [email protected].
Financial Disclosure Dr. Shifren has received research support from Proctor & Gamble (Cincinnati, OH) and consulting fees from Proctor & Gamble, Boehringer Ingelheim (Ingelheim, Germany), and Eli Lilly & Co. (Indianapolis, IN). She serves on the scientific advisory board for the New England Research Institutes (Watertown, MA). Dr. Monz is an employee of Boehringer Ingelheim. Dr. Russo is currently under contract with Boehringer Ingelheim and contributed to the development of the manuscript during the contract period. Drs. Segreti and Johannes performed work related to this article under a research contract with Boehringer Ingelheim and their employer, RTI Health Solutions (Research Triangle Park, NC).